Search Results - "Taj, Mary"

Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients by Taj, Mary M., Maecker‐Kolhoff, Britta, Ling, Rebecca, Bomken, Simon, Burkhardt, Birgit, Chiang, Alan K. S., Csoka, Monika, Füreder, Anna, Haouy, Stéphanie, Lazic, Jelena, Miakova, Natalia, Minard‐Colin, Veronique, Turner, Suzanne D., Uyttebroeck, Anne, Attarbaschi, Andishe

“…Summary Primary central nervous system (CNS) post‐transplant lymphoproliferative disorder (PTLD) in childhood is rare. Twenty‐five patients were retrieved from…”
Get full text

Management of paediatric monomorphic post‐transplant lymphoproliferative disorders with low‐intensity treatment: A multicentre international experience by Guerra‐García, Pilar, Bomken, Simon, Ling, Rebecca, Lazareva, Arina, Gupte, Girish, Amrolia, Persis, Andrés, Mara, Diez‐Sebastián, Jesús, Taj, Mary M.

“…Background Monomorphic post‐transplant lymphoproliferative disorder (mPTLD) is a major cause of morbidity/mortality following solid organ transplant (SOT),…”
Get full text

Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols by Taj, Mary M., Moorman, Anthony V., Hamadeh, Lina, Petit, Arnaud, Asnafi, Vahid, Alby-Laurent, Fanny, Vora, Ajay, Mansour, Marc R., Gale, Rosemary, Chevret, Sylvie, Moppett, John, Baruchel, André, Macintyre, Elizabeth

Get full text

Long‐term risk of portal hypertension and related complications in children treated with 6‐thioguanine for acute lymphoblastic leukemia: A single‐center experience by Roy Moulik, Nirmalya, M Taj, Mary

“…Long‐term follow‐up of 11 children with 6‐thioguanine‐induced hepatoportal toxicity is described. Features of persistent portal hypertension in eight patients…”
Get full text

Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders by Afify, Zeinab A. M., Taj, Mary M., Orjuela‐Grimm, Manuela, Srivatsa, Kavitha, Miller, Tamara P., Edington, Holly J., Dalal, Mansi, Robles, Joanna, Ford, James B., Ehrhardt, Matthew J., Ureda, Tonya J., Rubinstein, Jeremy D., McCormack, Sarah, Rivers, Julie M., Chisholm, Karen M., Kavanaugh, Madison K., Bukowinski, Andrew J., Friehling, Erika D., Ford, Maegan C., Reddy, Sonika N., Marks, Lianna J., Smith, Christine Moore, Mason, Clinton C.

“…Background Pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorder [EBV(−)M‐PTLD] comprises approximately…”
Get full text

Preliminary experience on the use of PET/CT in the management of pediatric post‐transplant lymphoproliferative disorder by Guerra‐García, Pilar, Hirsch, Steffen, Levine, Daniel S, Taj, Mary M.

“…Introduction Post‐transplant lymphoproliferative disorder (PTLD) is a well‐known complication following prolonged immunosuppression. Contrary to other…”
Get full text

Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia by Brown, Tanya, Swansbury, John, Taj, Mary M.

Get full text

Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia by Anoop, Parameswaran, Sankpal, Sushama, Stiller, Charles, Tewari, Sanjay, Lancaster, Donna L., Khabra, Komel, Taj, Mary M.

“…Abstract Patients with childhood relapsed and refractory mature B-cell non-Hodgkin lymphoma (B-NHL) and acute lymphoblastic leukemia (B-ALL) are rare and have…”
Get full text

Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe? by Lashkari, Harsha Prasada, Lancaster, Donna, Atra, Ayad, Champion, Michael P., Taj, Mary M.

“…Severe hyperlipidaemia with asparaginase therapy is rare. We report six cases, four of which developed significant problems with severe hyperlipidaemia during…”
Get full text

Comparison of Presentation and Outcome in 100 Pediatric Hodgkin Lymphoma Patients Treated at Children Hospital, Lahore, Pakistan and Royal Marsden Hospital, UK by Faizan, Mahwish, Taj, Mary M, Anwar, Saadia, Asghar, Nyla, Ahmad, Alia, Lancaster, Donna, Atra, Ayad, Ali, Agha Shabbir

“…To compare differences in demographics and outcomes in childhood Hodgkin lymphoma (HL) presenting at the Children's Hospital Lahore (CHL), and Royal Marsden…”
Get full text

Efficacy and tolerability of high‐dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children by Taj, Mary M., Messahel, Boo, Mycroft, Julie, Pritchard‐Jones, Kathy, Baker, Alistair, Height, Susan, Hadzic, Nedim, Pinkerton, C. Ross

“…Summary Childhood post‐transplant lymphoproliferative disease (PTLD) is a heterogeneous condition in which treatment varies, from the reduction of…”
Get full text

Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004 by Taj, Mary M., Hadzic, Nedim, Height, Susan E., Wotherspoon, Andrew, Burke, Margaret, Hobson, Rachel, Viskaduraki, Maria, Pinkerton, C. Ross

“…Abstract Prospective national registry data on 98 patients were studied to determine the long-term outcome of immune related lymphoproliferative disease (LPD)…”
Get full text

Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review by Messahel, Boo, Taj, Mary M., Hobson, Rachael, Hadzic, Nedim, Ramsay, Alan, Hann, Ian, Pinkerton, Ross

“…Survival in childhood lymphoproliferative disease (LPD) remains poor, particularly in non-transplant patients. The anti-CD20 antibody rituximab shows promise…”
Get full text

Use of volumetric-modulated arc therapy for treatment of Hodgkin lymphoma by Lee, Young K., Ph.D, Bedford, James L., Ph.D, Taj, Mary, M.D, Saran, Frank H., M.D., F.R.C.R

“…Abstract To evaluate volumetric-modulated arc therapy (VMAT) for treatment of Hodgkin lymphoma (HL) in patients where conventional radiotherapy was not…”
Get full text

Infection Prevention and Control Measures at the Children Hospital Lahore: A My Child Matters Collaborative Project by Faizan, Mahwish, Caniza, Miguela A, Anwar, Saadia, Kashif, Rahat-Ul-Ain, Saleem, Rabia, Javed, Humera, Zafar, Aizza, Taj, Mary Munaza, Hameed, Ambreen, Homsi, Maysam, Rathore, Ahsan Waheed, Sadiq, Masood, Gonzalez, Miriam, Zaidi, Alia

“…Infection prevention among children with cancer is a major challenge at Children Hospital Lahore (CHL), a public health care facility in Pakistan with 1,000…”
Get full text

Childhood post-transplant lymphoproliferative disorder by Srivatsa, Kavitha, Taj, Mary

“…Post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that occur as a serious complication of haematopoetic stem cell or…”
Get full text

Up to a Quarter of Children With Cancer Develop Breakthrough Clinical Varicella Despite Receiving Post-exposure Prophylaxis With Varicella Immunoglobulin: A Single Center UK Experience Over 3 Years by Prince, Nicholas J., Taj, Mary, Bate, Jessica M.

Get full text

Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatment by Macklin-Doherty, Aislinn, Jones, Michael, Coulson, Penny, Bruce, Cydney, Chau, Ian, Alexander, Emma, Iyengar, Sunil, Taj, Mary, Cunningham, David, Swerdlow, Anthony

“…Thyroid abnormalities are well reported following childhood treatment for Hodgkin Lymphoma (HL). Limited information exists for adult patients and after modern…”
Get full text

Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma by Newman, Alexander M., Zaka, Masood, Zhou, Peixun, Blain, Alex E., Erhorn, Amy, Barnard, Amy, Crossland, Rachel E., Wilkinson, Sarah, Enshaei, Amir, De Zordi, Julian, Harding, Fiona, Taj, Mary, Wood, Katrina M., Televantou, Despina, Turner, Suzanne D., Burke, G. A. Amos, Harrison, Christine J., Bomken, Simon, Bacon, Chris M., Rand, Vikki

“…Children with B-cell non-Hodgkin lymphoma (B-NHL) have an excellent chance of survival, however, current clinical risk stratification places as many as half of…”
Get full text

Pediatric EBV-negative monomorphic post–solid organ transplant lymphoproliferative disorders [EBV(-)M-PTLD]: Characteristics, treatment, and outcome from 11 pediatric academic centers by Afify, Zeinab A.M., Taj, Mary, Srivatsa, Kavitha, Miller, Tamara P., Edington, Holly, Dalal, Mansi, Robles, Joanna, Ford, James, Ehrhardt, Matthew J., Ureda, Tonya, Rubinstein, Jeremy, McCormack, Sarah, Rivers, Julia M., Chisholm, Karen M., Kavanaugh, Madison, Bukowinski, Andrew J., Friehling, Erika, Marks, Lianna, Smith, Christine Moore, Mason, Clinton

“…10012 Background: Pediatric EBV(-)M-PTLD comprises < 15% of M-PTLD. Two-year-overall survival of pediatric EBV(+) PTLD is 83%. No large multi-institution…”
Get full text